Related Experiment Videos

[Symptoms and natural history of cardiovascular diseases: obsolete?]

J P Delahaye1

  • 1Hôpital cardiologique, BP Lyon-Montchat.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|June 1, 1993
PubMed

Insights

Cardiovascular disease diagnosis increasingly relies on tests over symptoms. Re-emphasizing symptom assessment and understanding natural disease history is crucial for effective patient care and treatment decisions.

Area of Science:

  • Cardiology
  • Diagnostic Medicine
  • Clinical Epidemiology

Background:

  • The diagnostic role of symptoms in cardiovascular diseases has diminished.
  • Current practices often prioritize intervention over understanding the natural history and spontaneous outcomes of cardiovascular conditions.
  • While presymptomatic diagnosis and treatment offer benefits in specific cases (e.g., asymptomatic aortic regurgitation, silent ischemia), risks associated with misinterpretation and over-intervention exist.

Discussion:

  • Underassessment of patient complaints and excessive, context-lacking investigations can lead to diagnostic errors.
  • Patient-driven treatment choices and inadequate education on therapeutic options can result in suboptimal care.
  • The pursuit of intermediate physiological or anatomical goals, without proven impact on longevity or quality of life, is a concern.

Key Insights:

  • There is a disproportion between the limited number of validated therapies and the increasing number of interventions for asymptomatic patients.
  • Re-establishing the teaching of general pathology and the natural history of cardiovascular diseases is essential.
  • Symptom assessment in cardiovascular diagnosis should integrate physiopathological understanding, Bayesian predictive value analysis, and multiparameter scoring.

Outlook:

  • Future cardiovascular diagnosis should balance advanced testing with a renewed emphasis on clinical judgment informed by pathophysiology and evidence-based scoring systems.
  • Improved patient education and a focus on validated therapeutic outcomes are needed to guide treatment decisions.
  • A more nuanced approach is required, considering both the benefits of early intervention and the potential for favorable spontaneous disease progression.

Related Concept Videos